Modena / Adelaide, May 25th, 2022 – OrthoSpineNews –
Tsunami Medical Srl and Additive Surgical Pty Ltd today announced a strategic alliance with regards to both manufacturing and sales of 3D printed Spinal implant technology in Australia and New Zealand.
This successful alliance started 18 months ago with a question which was as simple as meaningful: “what is needed to become successful, introducing innovative technology into the ANZ markets?” And so was the answer: “Make sure you offer proven innovative technology and have it being manufactured in Australia for several reasons”.
“We’ve used all of 2021 and 2022 till today to establish an Australian team and manufacturing site following local needs and register products with TGA and have these Prosthesis listed”, says Additive’s CEO, Mr. Gibran Maher.
Peter Witke, Tsunami Medical’s CCO: “At Tsunami Medical we feel excited about sharing our intellectual property and experience, having Additive Surgical to manufacture and sell our clinically proven 3D printed technology; not as a foreign subsidiary of Tsunami, but as an independent company in Australia instead”.
Additive’s CEO concludes: “apart from contributing to Australia’s local economy and keeping both logistic and support mechanisms as local as possible, we also feel grateful about sharing the companies’ mutual core values of contributing to maintaining and restoring people’s health”.
For further information, please feel free to contact: Additive Surgical’s CEO, Mr. Gibran Maher: gibran@Additive-surgical.com or Tsunami Medical’s Chief Commercial Officer: peter.witke@tsunamimed.com”.
About the Company Tsunami Medical was founded in 1997, manufacturing invasive diagnostic devices as subcontractor of big manufacturing companies. Over the years the Company has bought the Bloodline trademark, very well known in the international biopsy and vertebroplasty spinal markets.
In 2010 Tsunami Medical started the design and manufacturing of Selective Laser Melting (SLM) technology, resulting in the currently available implant product portfolio.
Located in the heart of the “Biomedical Valley”, nearby Modena (Italy), the manufacturing facility extends on 1200 square meters with modern machinery and clean rooms class ISO 8, 13485 certified to design and manufacture medical devices.
What are you expectations for the Orthopedic and Spine industry for 2019?